XNAS 29 Apr, 2026 12:48 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Robert Ephron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2026 | 800 | 800 | - | - | Stock Option (Right to Buy) | |
| William S. Singer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2026 | 800 | 800 | - | - | Stock Option (Right to Buy) | |
| Bruce T. Bernstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2026 | 800 | 800 | - | - | Stock Option (Right to Buy) | |
| Alan J. Tuchman | Director, Chief Medical Officer | 31 Dec 2025 | 2,000 | 2,000 | - | - | Employee Stock Option (right to buy) | ||
| Robert Ephron | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.23 per share. | 17 Oct 2025 | 3,000 | 4,500 | - | 7.2 | 21,690 | Common Stock, par value $0.0001 per share |
| Robert Ephron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Oct 2025 | 7,500 | 7,500 | - | 0 | Common Stock, par value $0.0001 per share | |
| Robert Weinstein | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.23 per share. | 06 Aug 2025 | 4,000 | 16,574 | - | 7.2 | 28,920 | Common Stock, par value $0.0001 per share |
| Robert Weinstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2025 | 10,000 | 20,574 | - | 0 | Common Stock, par value $0.0001 per share | |
| Robert Weinstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2025 | 7,000 | 7,000 | - | - | Employee Stock Option (right to buy) | |
| Joshua Nathaniel Silverman | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.23 per share. | 06 Aug 2025 | 40,000 | 86,681 | - | 7.2 | 289,200 | Common Stock, par value $0.0001 per share |
| Joshua Nathaniel Silverman | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2025 | 100,000 | 126,681 | - | 0 | Common Stock, par value $0.0001 per share | |
| Bruce T. Bernstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2025 | 12,000 | 12,000 | - | - | Employee Stock Option (right to buy) | |
| Bruce T. Bernstein | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.23 per share. | 06 Aug 2025 | 10,000 | 30,897 | - | 7.2 | 72,300 | Common Stock, par value $0.0001 per share |
| Joshua Nathaniel Silverman | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2025 | 36,000 | 36,000 | - | - | Employee Stock Option (right to buy) | |
| Bruce T. Bernstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2025 | 25,000 | 40,897 | - | 0 | Common Stock, par value $0.0001 per share | |
| William S. Singer | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.23 per share. | 06 Aug 2025 | 6,000 | 19,566 | - | 7.2 | 43,380 | Common Stock, par value $0.0001 per share |
| William S. Singer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2025 | 15,000 | 25,566 | - | 0 | Common Stock, par value $0.0001 per share | |
| William S. Singer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2025 | 7,000 | 7,000 | - | - | Employee Stock Option (right to buy) | |
| Alan J. Tuchman | Director, Chief Medical Officer | 30 Jun 2025 | 1,726 | 3,909 | - | 7.8 | 13,549 | Common Stock, par value $0.0001 per share | |
| Robert Weinstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 15,410 | 16,738 | - | 0 | Common Stock, par value $0.0001 per share | |
| Robert Weinstein | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.85 per share. | 30 Jun 2025 | 6,164 | 10,574 | - | 7.8 | 48,387 | Common Stock, par value $0.0001 per share |
| Joshua Nathaniel Silverman | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.85 per share. | 30 Jun 2025 | 16,768 | 26,681 | - | 7.9 | 131,629 | Common Stock, par value $0.0001 per share |
| Joshua Nathaniel Silverman | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 41,919 | 43,449 | - | 0 | Common Stock, par value $0.0001 per share | |
| Bruce T. Bernstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 24,657 | 25,760 | - | 0 | Common Stock, par value $0.0001 per share | |
| Bruce T. Bernstein | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.85 per share. | 30 Jun 2025 | 9,863 | 15,897 | - | 7.9 | 77,425 | Common Stock, par value $0.0001 per share |
| William S. Singer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 15,410 | 16,730 | - | 0 | Common Stock, par value $0.0001 per share | |
| William S. Singer | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.85 per share. | 30 Jun 2025 | 6,164 | 10,566 | - | 7.8 | 48,387 | Common Stock, par value $0.0001 per share |
| Alan J. Tuchman | Director, Chief Medical Officer | 30 Jun 2025 | 4,315 | 5,635 | - | 0 | Common Stock, par value $0.0001 per share | ||
| William S. Singer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2025 | 800 | 800 | - | - | Stock Option (Right to Buy) | |
| Bruce T. Bernstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2025 | 800 | 800 | - | - | Stock Option (Right to Buy) | |
| William S. Singer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2024 | 800 | 800 | - | - | Stock Option (Right to Buy) | |
| Bruce T. Bernstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2024 | 800 | 800 | - | - | Stock Option (Right to Buy) | |
| Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2024 | 800 | 800 | - | - | Stock Option (Right to Buy) | |
| William S. Singer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| William S. Singer | Director | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 16 Dec 2022 | 27,000 | 33,000 | - | 1.2 | 31,641 | Common Stock, par value $0.0001 per share |
| Alan J. Tuchman | Director, Chief Executive Officer | 16 Dec 2022 | 27,000 | 33,000 | - | 1.2 | 31,641 | Common Stock, par value $0.0001 per share | |
| Robert Weinstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 16 Dec 2022 | 27,000 | 33,198 | - | 1.2 | 31,641 | Common Stock, par value $0.0001 per share |
| Joshua Nathaniel Silverman | Director | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 16 Dec 2022 | 19,012 | 38,238 | - | 1.2 | 22,280 | Common Stock, par value $0.0001 per share |
| Bruce T. Bernstein | Director | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 16 Dec 2022 | 22,500 | 27,578 | - | 1.2 | 26,368 | Common Stock, par value $0.0001 per share |
| Daniel L. Alkon | Director, President and CSO | 16 Dec 2022 | 19,688 | 35,546 | - | 1.2 | 23,072 | Common Stock, par value $0.0001 per share | |
| Robert Weinstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Alan J. Tuchman | Director, Chief Executive Officer | 15 Nov 2022 | 68,850 | 68,850 | - | - | Stock Option (Right to Buy) | ||
| Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Bruce T. Bernstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Daniel L. Alkon | Director, See Remark | 15 Nov 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | ||
| William S. Singer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Alan J. Tuchman | Director, Chief Executive Officer | 16 Feb 2022 | 6,150 | 6,150 | - | - | Stock Option (Right to Buy) | ||
| Alan J. Tuchman | Director, Chief Executive Officer | 13 Jul 2021 | 60,000 | 60,000 | - | 0 | Common Stock, par value $0.0001 per share | ||
| George Perry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2021 | 40,000 | 40,000 | - | 0 | Common Stock, par value $0.0001 per share | |
| William S. Singer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2021 | 60,000 | 60,000 | - | 0 | Common Stock, par value $0.0001 per share | |
| Daniel L. Alkon | Director, President and CSO | 13 Jul 2021 | 43,750 | 55,234 | - | 0 | Common Stock, par value $0.0001 per share | ||
| Bruce T. Bernstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2021 | 50,000 | 50,078 | - | 0 | Common Stock, par value $0.0001 per share | |
| Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2021 | 42,250 | 57,250 | - | 0 | Common Stock, par value $0.0001 per share | |
| Robert Weinstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2021 | 60,000 | 60,198 | - | 0 | Common Stock, par value $0.0001 per share | |
| Daniel L. Alkon | Director, Chief Scientific Officer | 14 Jun 2021 | 10,000 | 11,484 | - | 8.3 | 82,600 | Common Stock, par value $0.0001 per share | |
| Joshua Nathaniel Silverman | Director | Purchase of securities on an exchange or from another person at price $ 8.30 per share. | 14 Jun 2021 | 10,000 | 15,000 | - | 8.3 | 83,000 | Common Stock, par value $0.0001 per share |